---
title: "STOCKS | Hong Kong Biotech Stocks Surge with Innovent Biologics Leading Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288012307.md"
description: "Hong Kong's biotech sector saw significant gains as Innovent Biologicsrose over 10%, Akesoincreased by more than 6%, and WuXi AppTecclimbed over 5%. According to Jin10, the innovation-driven rally highlights investor confidence in the sector's growth potential."
datetime: "2026-05-29T05:03:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288012307.md)
  - [en](https://longbridge.com/en/news/288012307.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288012307.md)
---

# STOCKS | Hong Kong Biotech Stocks Surge with Innovent Biologics Leading Gains

Hong Kong's biotech sector saw significant gains as Innovent Biologics (01801.HK) rose over 10%, Akeso (09926.HK) increased by more than 6%, and WuXi AppTec (02359.HK) climbed over 5%. According to Jin10, the innovation-driven rally highlights investor confidence in the sector's growth potential.

### Related Stocks

- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)
- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)

## Related News & Research

- [Innovent Biologics Makes USD690 Million Structured Note Investments With JPMorgan and UBS](https://longbridge.com/en/news/287418100.md)
- [Luye Pharma announces annual general meeting](https://longbridge.com/en/news/288081186.md)
- [3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting](https://longbridge.com/en/news/287699826.md)
- [CICC Sticks to Their Buy Rating for Innovent Biologics (IVBXF)](https://longbridge.com/en/news/285050005.md)
- [Kelun-Biotech's Sac-TMT + Pembrolizumab Improves Survival In Late-Stage China Trial](https://longbridge.com/en/news/287276752.md)